Popular Articles From: CHS reports $378.7 million first-quarter earnings for fiscal 2015 to Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases


ST. PAUL, Minn.
Sign-up for CHS reports $378.7 million first-quarter earnings for fiscal 2015 investment picks
2015/1/7
PVH Corp.
Sign-up for PVH Corp. Announces Closing of Izod Retail Division investment picks
Raytheon Co.
Sign-up for Raytheon names Anthony O'Brien CFO, replacing David Wajsgras investment picks
2015/1/7
By Brett Arends, MarketWatch Buy what the herd is selling and hold on tight Peter Bennett, a money manager at Walker Cripps in London, has a longstanding rule that has served him and his clients extremely well for almost 50 years.
Sign-up for UPDATE: Greece is the word for fearless stock investors in 2015 investment picks
2015/1/7
Preschoolers will enter a whimsical world of spellbinding adventures when Little Charmers , a brand-new animated preschool series that celebrates the magic of friendship, debuts Monday, Jan.
Sign-up for Little Charmers ‘Turns on the Charm’ on Nickelodeon Monday, Jan. 12, at 12 P.M. (ET/PT) investment picks
2015/1/7
By Justin Scheck For years, big oil companies have been spending more money than they bring in.
Sign-up for Oil Firms' New Dilemma: Save, or Borrow More? investment picks
SIGA Technologies, Inc. (Nasdaq:SIGA), a company operating under the protection of the United States Bankruptcy Court for the Southern District of New York and specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced that on January 7, 2015, the Delaware Court of Chancery, acting on remand from the Delaware Supreme Court, issued a letter opinion in the litigation begun by PharmAthene, Inc. in 2006.
Sign-up for Delaware Court Decision Regarding SIGA Technologies, Inc. investment picks
2015/1/7
HOUSTON , Jan.
Sign-up for Sanchez Energy Announces Updated 2015 Capital Plan And Guidance investment picks
Alorica , a worldwide leading provider of customer management outsourcing solutions, today announced it has signed an agreement to acquire several of West Corporation’s (NASDAQ: WSTC) agent services businesses for a consideration of $275 million.
Sign-up for Alorica Announces Strategic Acquisition of West Corporation’s Agent Services Businesses investment picks
Intuit Inc. (Nasdaq:INTU), maker of Intuit Tax Online ®, ProSeries® and Lacerte®, the nation’s leading tax software for tax professionals, launched Understanding the Affordable Care Act, a free online resource to help tax professionals understand and prepare for the tax implications brought about by health care reform.
Sign-up for Intuit Launches Comprehensive Guide to Help Tax Professionals Prepare for Affordable Care Act Tax Changes investment picks
2015/1/7
Surge Energy Inc. exceeds 2014 exit rate; announces capital program for first half of 2015; reduces dividend Canada NewsWire CALGARY , Jan.
Sign-up for Surge Energy Inc. exceeds 2014 exit rate; announces capital program for first half of 2015; reduces dividend investment picks
Signature Bank (Nasdaq: SBNY), a New York-based full-service commercial bank, announced today that it was named the best bank in America by Forbes in the publication’s annual list of America’s Best and Worst Banks 2015 .
Sign-up for Signature Bank Named Best Bank in America by Forbes investment picks
The latest in the historic line of award-winning JBL Loudspeakers LAS VEGAS , Jan.
Sign-up for JBL® Arena Series, The next Generation of affordable High-Performance Loudspeakers investment picks
2015/1/6
By Tim Mullaney The president could push Republicans into a broader deal that extends his own policies For all of Barack Obama's activism as president, one of his biggest triumphs came when he shut up and did little: He stood aside and let private energy businesses create a boom out of hydraulic fracking, which has slashed natural gas prices by two-thirds and is busily doing the same to oil.
Sign-up for UPDATE: Why Obama should OK the Keystone Pipeline investment picks
BERKELEY HEIGHTS, N.J., Jan.
Sign-up for Cyclacel Pharmaceuticals to Present at the Biotech Showcase(TM) 2015 Conference investment picks
MIDDLETOWN, R.I., Jan.
Sign-up for KVH TracVision A9 Brings Satellite TV Services to Vehicles investment picks
Alkermes plc (NASDAQ: ALKS) today announced topline results from FORWARD-1, one of a series of supportive clinical studies in the comprehensive FORWARD phase 3 pivotal program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD). The FORWARD-1 study was designed to evaluate the safety and tolerability of two titration schedules of ALKS 5461.
Sign-up for Alkermes Announces Positive Results From Study of ALKS 5461 for Treatment of Major Depressive Disorder investment picks
The Kentucky Board of Medical Imaging and Radiation Therapy (KBMIRT) has released two new online services, offering both professionals and citizens increased access to licensee information and a more convenient license renewal process.
Sign-up for The Kentucky Board of Medical Imaging and Radiation Therapy Releases Two New Online Services investment picks
BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that its Chief Executive Officer, Kinneret Savitsky, Ph.D., and its Chief Financial and Operating Officer, Philip Serlin, will be presenting at the Biotech Showcase 2015 Conference being held at the Parc 55 Wyndham Union Square Hotel in San Francisco, CA.
Sign-up for BioLineRx to Present at Biotech Showcase 2015 Conference in San Francisco investment picks
2015/1/6
By MarketWatch, MarketWatch LONDON (MarketWatch) -- European stocks erased early losses, rising as oil futures pared steep declines and U.S. stock futures turned higher on Tuesday.
Sign-up for UPDATE: European stocks turn higher investment picks
Enhances preeminent Michigan-based retail banking franchise with addition of leading, entrepreneurial, relationship-oriented commercial bank Adds approximately $1.2 billion in assets, $1.0 billion in deposits, and $0.9 billion in loans Augments Michigan's largest branch network outside of the Detroit MSA with additional locations in high-growth MSAs Results in estimated 10% EPS accretion in first full year MIDLAND, Mich.
Sign-up for Chemical Financial Corporation to Partner With Lake Michigan Financial Corporation investment picks
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan.
Sign-up for Oxford Immunotec Announces Completion of Re-Registration in China for T-SPOT.TB Test investment picks
NEW YORK and LAS VEGAS , Jan.
Sign-up for WebMD and Robin Roberts to Develop New Video Programming That Explores The Future of Health investment picks
ACI Worldwide (NASDAQ: ACIW), a leading global provider of electronic payment and banking solutions , today announced its participation at NRF's Annual Convention & Expo, January 11-13, 2015 in New York City.
Sign-up for ACI Worldwide Showcases EMV Readiness at NRF 2015 investment picks
HARMAN, the premium global audio, visual, infotainment and enterprise automation group (NYSE:HAR), introduced today at CES 2015 the JBL® Concert Edition plug-and-play audio upgrade package.
Sign-up for HARMAN Introduces the JBL Concert Edition Plug and Play Audio Upgrade; Launches Ford F-150 Package investment picks
Marvell's AP3200 Reference Platform combines award-winning ARMADA and Avastar product lines and integrates dual concurrent 802.11 radios (4x4 802.11ac Wave-2 with 160MHz support and Multi-User, Multiple Input and Multiple Output (MU-MIMO) and 4x4 802.11n with 256 QAM support) for next-generation enterprise and home connectivity applications SANTA CLARA, Calif.
Sign-up for Marvell Introduces Industry's Highest Performance 4x4 802.11ac Wave-2 Wi-Fi and System-on-Chip Platform for Enterprise Access Point and Smart Home Gateway Solutions investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0986386001&sourceType=1 http://media3.marketwire.com/logos/20140805-cresnt.jpg CALGARY, ALBERTA --
Sign-up for Crescent Point Energy Announces $1.45 Billion Capital Expenditures Budget for 2015 investment picks
2015/1/6
By Gaurav Raghuvanshi And Richard C.
Sign-up for AirAsia Flight 8501 Crash: Time Running Out to Recover Floating Bodies -- 3rd Update investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) and Phenex Pharmaceuticals AG, a privately-held biotechnology company, today announced the signing of a definitive agreement under which Gilead will acquire Phenex’s Farnesoid X Receptor (FXR) program comprising small molecule FXR agonists for the treatment of liver diseases including nonalcoholic steatohepatitis (NASH). Under the terms of the agreement, Gilead will pay Phenex an upfront payment plus additional payments based upon achievement of certain development milestones that may potentially be worth up to $470 million.
Sign-up for Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: CHS reports $378.7 million first-quarter earnings for fiscal 2015 to Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent